Plaintiff Awarded $2.3 Million for Actos Bladder Cancer

Takeda Pharmaceuticals Loses Another Actos Bladder Cancer Lawsuit

Actos Bladder CancerTakeda Pharmaceuticals must pay another penalty, this time $2.3 million, for Actos bladder cancer injuries caused by the blockbuster Type 2 diabetes drug Actos, which has been tied to bladder cancer in numerous patients.

On Thursday, February 12th, plaintiff John Kristufek was awarded $2.3 million for pain and suffering caused by developing Actos bladder cancer after taking Actos for some years to treat his Type 2 diabetes.

The jury also ruled that Takeda showed “reckless indifference” to Kristufek’s and other patients’ health by hiding the risks of Actos. The finding could lead to punitive damages against Takeda, which will be awarded by the judge.

During the course of the trial, Takeda argued that the plaintiff’s bladder cancer could not have been directly caused by Actos, and instead must be related to his long history of smoking. Although Kristufek smoked for 25 years, he quit in 1990, and a University of Colorado oncologist, Shandra Wilson, testified in his trial in mid-January that Actos is the only drug that could have caused Kristufek’s bladder cancer.

“To me it appears that the higher the dose, the more likely it is that Actos causes bladder cancer,” Wilson said. “I do believe it was a substantial factor.” She added that Kristufek’s smoking history did increase his chances of developing cancers, including bladder cancer, about 10 to 20%, but that Actos was 4 times more likely to cause the development of those specific tumors.

Kristufek took Actos for 3 years for his Type 2 diabetes, and was diagnosed with bladder cancer after his doctor found tumors in his bladder in 2008.

Kristufek is the fifth patient in a long line of Actos patients who filed a personal injury lawsuit against Takeda for pain and suffering due to bladder cancer, who has won his personal injury trial.

Currently, Takeda Pharmaceuticals faces over 3,500 personal injury lawsuits in a multidistrict litigation (MDL) which allege that Actos caused the plaintiffs’ bladder cancer. In a previous ruling, Takeda managed to drastically reduce a penalty – from $9 billion between Takeda and former partner Eli Lilly, to $37 million between the two.

The Strom Law Firm Can Help with Personal Injury and Wrongful Death Cases, Including Actos Bladder Cancer Lawsuits

Evidence strongly links Actos to increased risk of bladder cancer, but the drug also has other dangerous side effects. If you or a loved one take Actos or the generic, pioglitazone, to treat Type 2 diabetes, and have since developed bladder cancer, heart disease, liver failure, or diabetic macular edema, you may be entitled to compensation.

There are several side effects associated with Actos®.

You should seek medical attention if you experience:

  • shortness of breath or trouble breathing,
  • chest pain,
  • extreme fatigue,
  • irregular heartbeat,
  • dilated neck veins,
  • swelling of face, fingers, feet, or lower legs,
  • decreased urine output, and
  • weight gain

If you or a loved one have taken Actos to treat Type 2 diabetes, and have since suffered dangerous side effects including developing bladder cancer you may be entitled to compensation. The attorneys at the Strom Law Firm can help with personal injury cases, including against Actos manufacturer Takeda Pharmaceuticals. We offer free, confidential consultations to discuss the facts of your case, so do not hesitate to contact us803.252.4800

About Pete Strom

Defending criminal charges including drug crimes, DUI, CDV, mail fraud, wire fraud, bank fraud, computer crimes, money laundering, and juvenile crimes, Pete also handles Federal and State investigations. Representing individuals in Civil Matters including Class Actions, Personal Injury, Qui Tam Actions, Defective Products, Nursing Home Neglect, and Professional Licensing Defense cases. Joseph Preston “Pete” Strom, Jr., the managing partner at Strom Law Firm, L.L.C., has been fighting for justice since 1984.

Leave a Reply

BestLawyers.comAVBetter Business Bureau